Investview, Inc. Reports Third-Quarter 2026 Financial Results and Strategic Business Update
Key Highlights
- ➤Q3 net revenue $2.2 million, down 72.5% year over year
- ➤Q3 net income $9.0 million, driven mainly by $10.8 million investment-sale proceeds
- ➤Conectiv Q3 net revenue $1.8 million, down 74.1% year over year
- ➤Cash, cash equivalents and digital assets reached $18.6 million, up 20.4%
- ➤Opencash targets initial commercial operations by end-Q2 2027, remaining pre-revenue
Expert Statements
Victor Oviedo, Chief Executive Officer of Investview
“Our third-quarter results reflect both the challenges of an ongoing business transition and the progress we are making in strengthening our financial position. Although during the quarter our net revenue declined to $2.2 million, and we reported an operating loss (excluding discontinued operations) of $2.1 million, and net income of $9.0 million, we also significantly enhanced our liquidity as we sold for $10.8 million our equity investment in an early-stage nuclear power and infrastructure technology company. While the resulting gain was non-operating, the additional liquidity gives us greater flexibility as we address operating performance. We ended the quarter with $18.6 million in cash, cash equivalents, and digital assets and a current ratio of 2.83, and we continued repurchasing shares under our authorized program.”
Victor Oviedo, Chief Executive Officer of Investview
“We are mindful of our continued losses from operations, and we remain laser focused on rationalizing our business portfolio, allocating capital with discipline, and managing costs carefully. We need to continue to execute on the strategic initiatives adopted by the Company intended to strengthen member engagement and retention at Conectiv, expand product sales at MyLife Wellness, rebuild profitable manufacturing volume at Renu Laboratories, and advance Opencash toward commercial launch. We will evaluate each business based on its operating performance, profitability, cash flow, and capital requirements, with the objective of strengthening our financial foundation and creating long-term shareholder value.”
Haverford, PA, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Investview, Inc. (OTCQB: INVU) (the “Company”) today reported financial results for the third quarter ended September 30, 2026, and provided an update on operating activity during the quarter. The quarter reflected a continued contraction in the Company's marketing network, a 10% increase in revenue from its health, beauty, and wellness businesses versus the second quarter of 2026, and continued investment in pre-commercial operations. Net income for the quarter was $9.0 million versus a $3.2 million loss in the second quarter of 2026, primarily attributable to the sale of the Company’s equity investment in an early-stage nuclear power and infrastructure technology company. The sale generated $10.8 million in net cash proceeds, strengthening the Company's financial position while its operating businesses continued to face challenges. Management will continue to focus on simplifying the portfolio, strengthening capital-allocation discipline, and clarifying the roles of its operating businesses, including selective commercial integration among Conectiv, MyLife Wellness, and Renu Laboratories.
Get started
Create a free account to read the full story.